ATP-competitive kinase inhibitors

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug NameATP-competitive kinase inhibitors
Drug Alias NameeCF-309
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerine/threonine-protein kinase mTOR inhibitors
TargetsSerine/threonine-protein kinase mTOR
Therapy Area/IndicationsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesThe University Of Edinburgh
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesThe University Of Edinburgh
Active IndicationsN/A
Inactive IndicationsBreast Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A